Tumor necrosis factor receptor superfamily member 1A
| GO Term | Evidence Code | Reference |
|---|---|---|
| aortic valve development | ||
| pulmonary valve development | ||
| negative regulation of extracellular matrix constituent secretion | ||
| prostaglandin metabolic process | ||
| prostaglandin metabolic process |
| GO Term | Evidence Code | Reference |
|---|---|---|
| Golgi membrane | ||
| Golgi membrane | ||
| Golgi membrane | ||
| obsolete extracellular space |
|
|
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| protease binding | ||
| tumor necrosis factor receptor activity | ||
| tumor necrosis factor receptor activity | ||
| tumor necrosis factor receptor activity | ||
| tumor necrosis factor receptor activity |
| Pathway Name | Organism |
|---|---|
| Regulation of TNFR1 signaling | Mus musculus |
| TNF signaling | Mus musculus |
| TNFR1-induced NF-kappa-B signaling pathway | Mus musculus |
| TNFR1-induced proapoptotic signaling | Mus musculus |
| TNFR1-mediated ceramide production | Mus musculus |
| TNFs bind their physiological receptors | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0090018 | TNF receptor–associated periodic syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026